Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 12, 2024 20:27 ET | Source: Actuate Therapeutics

Actuate Therapeutics Announces Pricing of Initial Public Offering

CHICAGO and FORT WORTH, Texas, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Nasdaq: ACTU) (the “Company”), a clinical stage biopharmaceutical company focused on developing therapies...
May 28, 2024 07:00 ET | Source: Actuate Therapeutics

Actuate Therapeutics Files Registration Statement for Initial Public Offering

CHICAGO and FORT WORTH, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (“Actuate”) announced today that it has filed a registration statement with the Securities and Exchange...
April 08, 2024 08:00 ET | Source: Actuate Therapeutics

Actuate Therapeutics Announces Poster Presentations at the 2024 AACR Annual Meeting

CHICAGO and FORT WORTH, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, announced today two poster presentations from...
August 01, 2023 08:00 ET | Source: Actuate Therapeutics

Actuate Therapeutics Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Pancreatic Cancer

CHICAGO and FORT WORTH, Texas, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, today announced that the U.S. Food and Drug...
May 30, 2023 08:00 ET | Source: Actuate Therapeutics

Actuate Therapeutics Announces Poster Presentations at the 2023 ASCO Annual Meeting

CHICAGO and FORT WORTH, Texas, May 30, 2023 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, announced today four presentations from scientific...
April 10, 2023 10:22 ET | Source: Actuate Therapeutics

UPDATE -- Actuate Therapeutics Announces Poster Presentations at the 2023 AACR Annual Meeting

CHICAGO and FORT WORTH, Texas, April 10, 2023 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, announced today three poster presentations from...
April 10, 2023 07:59 ET | Source: Actuate Therapeutics

Actuate Therapeutics Announces Poster Presentations at the 2023 AACR Annual Meeting

CHICAGO and FORT WORTH, Texas, April 10, 2023 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, announced today three poster presentations from...
March 23, 2023 10:36 ET | Source: Actuate Therapeutics

Actuate Therapeutics Congratulates Dr. Patricia LoRusso on Being Named AACR President-Elect

CHICAGO and FORT WORTH, Texas, March 23, 2023 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc., a Chicago-based clinical-stage biopharmaceutical company advancing lead drug elraglusib (a novel GSK-3...
October 18, 2022 07:50 ET | Source: Actuate Therapeutics

Drs. Roger B. Cohen, Lee M. Ellis and John L. Marshall Join Actuate Therapeutics’ Scientific Advisory Board

CHICAGO and FORT WORTH, Texas, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc., a Chicago-based clinical-stage biopharmaceutical company advancing lead drug elraglusib (a novel GSK-3...
March 28, 2022 07:50 ET | Source: Actuate Therapeutics

Actuate Therapeutics Announces Poster Presentations at the 2022 AACR Annual Meeting

CHICAGO and FORT WORTH, Texas, March 28, 2022 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, announced today two poster presentations from...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right